Filing Details

Accession Number:
0001209191-19-042975
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-23 16:59:15
Reporting Period:
2019-07-22
Accepted Time:
2019-07-23 16:59:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645666 Kezar Life Sciences Inc. KZR Pharmaceutical Preparations (2834) 473366145
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769674 Vassiliki Economides C/O Kezar Life Sciences, Inc.
4000 Shoreline Court, Suite 300
South San Francisco CA 94080
Svp, Strategy & External Aff. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-22 431 $5.82 431 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.79 to $5.83 on July 22, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.